CDTX Insider Trading
Insider Ownership Percentage: 7.64%
Insider Buying (Last 12 Months): $105,680.00
Insider Selling (Last 12 Months): $86,231.88
Cidara Therapeutics Insider Trading History Chart
This chart shows the insider buying and selling history at Cidara Therapeutics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Cidara Therapeutics Share Price & Price History
Current Price: $20.89
Price Change: ▼ Price Decrease of -0.23 (-1.09%)
As of 04/30/2025 05:00 PM ET
Cidara Therapeutics Insider Trading History
Cidara Therapeutics Institutional Trading History
Data available starting January 2016
Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. The company was incorporated in 2012 and is based in San Diego, California.
Read More on Cidara Therapeutics
Today's Range
Now: $20.89
52 Week Range
Now: $20.89
Volume
59,424 shs
Average Volume
71,440 shs
Market Capitalization
$228.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.89
Who are the company insiders with the largest holdings of Cidara Therapeutics?